AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in early-stage stomach cancer met its main goal. When added to a ...

Toronto — Canada's Liberal Party has chosen veteran central bank leader Mark Carney as its new leader, meaning he will quickly replace Prime Minister Justin Trudeau in the country's top office.

Former central banker Mark Carney will become the next prime minister of Canada after winning the race to lead the country’s governing Liberal Party on Sunday. In his first speech as party ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Former Bank of England governor Mark Carney has been named Canadian prime minister after winning the Liberal Party leadership in a landslide victory. Mr Carney, who also used to head up Canada's ...

TORONTO — Former central banker Mark Carney will become Canada’s next prime minister after the governing Liberal Party elected him its leader Sunday as the country deals with President Trump ...

Mark Carney, 59, who steered the Bank of Canada through the 2008 global financial crisis and the Bank of England through Brexit, but who has never been elected to office, won a leadership race on ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer.

First, Bloomberg's Mark Gurman today briefly mentioned that iOS 19 will likely expand some existing Apple Intelligence features to more of Apple's apps. Second, he was told that visionOS 3 will be ...

Mark Carney is the UN Special Envoy on Climate Action and Finance, coming from a distinguished career in finance that included serving as Governor of the Bank of England. In a recent interview, he ...

AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower cholesterol. The new ...

In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in the UK, after the government reduced the offer on the table to ...